07 Sep, 2025
5 mins read

Do pediatricians recommend vaccines to make a profit?

Credit: Gustavo Fring from Pexels It makes sense to approach some marketing efforts with skepticism. Scams, deepfakes, and deceptive social media posts are common, with people you don’t know seeking to profit from your behavior. But should people extend this same skepticism to pediatricians who advise vaccines for children? Health and Human Services Secretary Robert […]

2 mins read

Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC, trial shows

Credit: Pixabay/CC0 Public Domain An analysis from the Phase III CheckMate 77T trial confirms that perioperative nivolumab does not compromise health-related quality of life (HRQoL) in patients with resectable non-small cell lung cancer (NSCLC), including those with Stage III N2 disease. These results were presented at the International Association for the Study of Lung Cancer […]

2 mins read

Iza-bren and osimertinib combination shows 100% response rate in EGFR-mutated lung cancer

Credit: Unsplash/CC0 Public Domain A combination of iza-bren (BL-B01D1), a novel bispecific antibody-drug conjugate (ADC), with osimertinib demonstrated a 100% objective response rate (ORR) in patients with first-line EGFR-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC). This study was presented at the International Association for the Study of Lung Cancer 2025 World Conference […]

2 mins read

Osimertinib plus chemotherapy improves progression-free survival in EGFR-mutated non-small cell lung cancer

Credit: Pixabay/CC0 Public Domain A new analysis from the COMPEL trial shows that patients with EGFR-mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) who experienced non-central nervous system (CNS) progression on first-line osimertinib benefit from continuing osimertinib treatment in combination with platinum-based chemotherapy. The study was presented at the International Association for the Study of […]

2 mins read

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Credit: CC0 Public Domain A novel antibody-drug conjugate (ADC), iza-bren (BL-B01D1), demonstrates encouraging safety and efficacy results in previously treated patients with EGFR-mutated non-small cell lung cancer (NSCLC), according to findings presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC). Iza-bren is a first-in-class EGFR […]

3 mins read

AI lung cancer risk model validated in predominantly Black population at hospital

Credit: Kampus Production from Pexels A new study presented at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC) validates the use of Sybil, a deep learning artificial intelligence model, for predicting future lung cancer risk in a predominantly Black population. The study, conducted by the University of […]